Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108484518B details a novel copper-catalyzed C-H selenylation route using elemental selenium, offering high yields and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN121517448A reveals copper-catalyzed synthesis for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Patent CN112979545B reveals a metal-free route to 5-selenoquinolines using PIFA. This method offers high regioselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN110747489B reveals a novel electroreduction method for 2-amino-4-methoxybenzoic acid derivatives, offering high-purity intermediates for Gefitinib with reduced environmental impact.
Patent CN106187815A reveals a novel Ni-Salen cage catalyst for high-selectivity sulfoxide synthesis. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN108164501A enables mild carbonyl sulfide conversion for high-purity intermediates. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Patent CN101747302A details a novel iron-catalyzed method for synthesizing polysubstituted benzofurans, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturers.
Patent CN111235599A details a green electrochemical method for tetraarylhydrazines. Eliminate metal catalysts for cost-effective, high-purity pharmaceutical intermediate manufacturing.
Patent CN103772189A details a scalable 13-step synthesis for Methyl Cajanonic Acid A, offering a robust alternative to natural extraction for hypoglycemic drug development.
Patent CN102381918A details a safe copper-catalyzed route to benzyl cyanides using potassium ferrocyanide, offering significant cost and safety advantages for supply chains.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN107629020B reveals a metal-free synthesis route for 4H-1,2,4-oxadiazine-5(6H)-one derivatives, offering cost-effective manufacturing for agrochemical and pharmaceutical intermediates.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Novel heterogeneous catalyst method reduces Pd usage and enables recycling for sustainable furan derivative production.
Patent CN102351907A reveals a nickel-mediated transmetallation route for diverse metal-NHC catalysts, offering cost-effective manufacturing for pharmaceutical and fine chemical applications.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Novel solvent-free dependent synthesis route offers high purity and scalable production for agrochemical intermediates. Reduces cost and enhances supply chain reliability significantly.
Patent CN112979665B details novel griseofulvin derivatives with potent antitumor activity via Schmidt rearrangement, offering cost-effective routes for API intermediates.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.